Interaction between secondary mitral regurgitation and left atrial function and their prognostic implications after cardiac resynchronization therapy

Author:

Stassen Jan12ORCID,Galloo Xavier13ORCID,Hirasawa Kensuke1ORCID,van der Bijl Pieter1ORCID,Leon Martin B4,Marsan Nina Ajmone1,Bax Jeroen J15

Affiliation:

1. Department of Cardiology, Leiden University Medical Center , Albinusdreef 2, 2300 RC Leiden , The Netherlands

2. Department of Cardiology, Jessa Hospital , Stadsomvaart 11, 3500 Hasselt , Belgium

3. Department of Cardiology, Universitair Ziekenhuis Brussel , Laarbeeklaan 101, 1090 Brussels , Belgium

4. Department of Cardiology, Columbia University Irving Medical Center/Presbyterian Hospital and Cardiovascular Research Foundation , New York, NY 10032 , USA

5. Turku Heart Center, University of Turku and Turku University Hospital , Kiinamyllynkatu 4-8, FI-20520 Turku , Finland

Abstract

Abstract Aims Left atrial (LA) function is a strong prognostic marker in patients with heart failure and functional mitral regurgitation (MR). Although cardiac resynchronization therapy (CRT) has shown to improve MR severity, the interaction between a reduction in MR severity and an increase in LA function, as well as its association with outcomes, has not been investigated. Methods and results LA reservoir strain (RS) was evaluated with speckle tracking echocardiography in patients with at least moderate functional MR undergoing CRT implantation. MR improvement was defined as at least 1 grade improvement in MR severity at 6 months after CRT implantation. The primary endpoint was all-cause mortality. A total of 340 patients (mean age 66 ± 10 years, 73% male) were included, of whom 200 (59%) showed MR improvement at 6 months follow-up. On multivariable analysis, an improvement in MR severity was independently associated with an increase in LARS (odds ratio 1.008; 95% confidence interval 1.003–1.013; P = 0.002). After multivariable adjustment, including baseline and follow-up variables, an increase in LARS was significantly associated with lower mortality. MR improvers showing LARS increasement had the lowest mortality rate, whereas outcomes were not significantly different between MR non-improvers and MR improvers showing no LARS increasement (P = 0.236). Conclusion A significant reduction in MR severity at 6 months after CRT implantation is independently associated with an increase in LARS. In addition, an increase in LARS is independently associated with lower all-cause mortality in patients with heart failure and significant functional MR.

Funder

European Society of Cardiology

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Reference32 articles.

1. Prognostic implications of mitral regurgitation in patients after cardiac resynchronization therapy;Cipriani;Eur J Heart Fail,2016

2. Refining the prognostic impact of functional mitral regurgitation in chronic heart failure;Goliasch;Eur Heart J,2018

3. Prediction of left atrial fibrosis with speckle tracking echocardiography in mitral valve disease: a comparative study with histopathology;Her;Korean Circ J,2012

4. Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3;Zivlas;Ther Adv Cardiovasc Dis,2017

5. Left atrial dynamics during exercise in mitral regurgitation of primary and secondary origin: pathophysiological insights by exercise echocardiography combined with gas exchange analysis;Sugimoto;JACC Cardiovasc Imaging,2020

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3